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Abstract
HIRA is a histone chaperone known to modulate gene expression through the deposition of H3.3. Conditional knockout 
of Hira in embryonic mouse hearts leads to cardiac septal defects. Loss of function mutation in HIRA, together with other 
chromatin modifiers, was found in patients with congenital heart diseases. However, the effects of HIRA on gene expression 
at earlier stages of cardiogenic mesoderm differentiation have not yet been studied. Differentiation of mouse embryonic stem 
cells (mESCs) towards cardiomyocytes mimics some of these early events and is an accepted model of these early stages. 
We performed RNA-Seq and H3.3-HA ChIP-seq on both WT and Hira-null mESCs and early cardiomyocyte progenitors 
of both genotypes. Analysis of RNA-seq data showed differential down regulation of cardiovascular development-related 
genes in Hira-null cardiomyocytes compared to WT cardiomyocytes. We found HIRA-dependent H3.3 deposition at these 
genes. In particular, we observed that HIRA influenced directly the expression of the transcription factors Gata6, Meis1 and 
Tbx2, essential for cardiac septation, through H3.3 deposition. We therefore identified new direct targets of HIRA during 
cardiac differentiation.
Keywords HIRA · H3.3 · Heart · Cardiomyocytes · Embryonic stem cells · Differentiation · Enhancers
Introduction
Heart development is a complex process involving cardio-
genic mesodermal differentiation into endocardium and 
myocardium. The myocardium is generated sequentially 
from cardiac precursors, primitive cardiomyocytes and 
definitive cardiomyocytes [1]. It requires a tightly controlled 
temporal gene expression pattern, which if disturbed can 
lead to the development of congenital heart diseases [2]. 
For example, mutations in Gata4 or Tbx2, important cardiac 
transcription factors, are associated with endocardial cushion 
and cardiac septal defects [3, 4]. Chromatin modifications 
and histone variants are essential for lineage commitment 
and cell fate [5, 6]. A distinct chromatin pattern specific for 
each stage of stem cell differentiation into cardiomyocytes 
was reported [7]. The histone variant H3.3 plays a role in 
early embryonic development [8] and lineage commitment 
of stem cells [9–11]. HIRA is required for genome wide 
enrichment of the histone variant H3.3 at active and bivalent 
genes in mouse embryonic stem cells (mESCs) [11].
HIRA is part of one of the two complexes that depos-
its H3.3 in a replication independent manner [12, 13]. The 
HIRA complex includes UBN1, CABIN1 and ASF1 [14]. It 
deposits H3.3 at the gene bodies of developmentally regu-
lated genes [11], highly active genes [10] and some active 
enhancers and regulatory elements [15]. It has also been 
shown that there is HIRA-independent H3.3 enrichment 
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at certain transcription factor binding sites (TFBS) and at 
telomeres in undifferentiated mESCs in a ATRX/DAXX 
dependent manner [10].
Absence of HIRA in mice [16] and Xenopus laevis [17] 
leads to gastrulation defects and embryonic lethality. Attenu-
ation of Hira expression in chick cardiac neural crest results 
in common arterial trunk, suggesting a role for HIRA in out-
flow tract (OFT) septation [18]. Hira-null mouse embryos 
showed abnormal heart looping and pericardial oedema at 
embryonic day (E)10.5 [16]. Recently, HIRA was found to 
be one of 46 chromatin modifiers that had a significant loss 
of function mutation (p value = 0.03) in a large congenital 
heart disease cohort study [19]. We previously published 
that conditional knockout of Hira in the cardiogenic meso-
derm resulted in embryonic lethality with atrial and ven-
tricular septal defects at E15.5. Following genome-wide 
analysis of the transcriptome of these conditional knockout 
mouse hearts at E12.5, we identified a dysregulation of cer-
tain cardiac genes such as Tnni2, Tnnt3 and Epha3 [20]. We 
showed HIRA-dependent H3.3 deposition at the enhancer 
Tte that regulates the expression of Tnni2 and Tnnt3 during 
cardiac development.
However, the role of HIRA at the early stages of cardio-
genic mesoderm differentiation has not been studied. Dif-
ferentiation of mESCs towards cardiomyocytes mimics the 
early stages of cardiogenic mesodermal differentiation [7, 
21]. Here, we used in vitro mESC differentiation to study 
the role of HIRA during this process and focused on day 15, 
when the cardiogenic mesoderm genes are expressed [22]. 
High-throughput RNA sequencing (RNA-seq) and H3.3-HA 
chromatin immunoprecipitation followed by massive parallel 
sequencing (ChIP-seq) were then performed on both WT 
and Hira-null undifferentiated and mESC-derived cardio-
myocytes at day 15 of differentiation. We report here that 
HIRA is required for the expression of cardiac transcrip-
tion factors involved in septation during cardiac develop-
ment. These transcription factors displayed diminished H3.3 
enrichments in their gene bodies or near their Transcription 
Start Site (TSS) in the absence of HIRA. This reflects the 
requirement for HIRA in the expression of important cardiac 
transcription factors through H3.3 deposition.
Methods
Cell culture and differentiation
H3.3-HA tagged wild type (W9.5) and Hira-null (Clone 
104) mESCs have been cultured and maintained as described 
previously [22]. These cells were maintained in an undif-
ferentiated state at 37  °C and 5%  CO2 on 0.1% gelatin 
coated flasks in Knockout™ D-MEM (GIBCO, 10829), 
supplemented with 15% ES-FCS (Millipore ES-009B), 1× 
Glutamax (GIBCO 35050-038), 1× Penicillin/Streptomy-
cin (GIBCO 15140), 1× MEM NEAA (GIBCO 11140-035), 
0.1 mM 2-β-mercaptoethanol (SIGMA M-7522) and  103 
Units/ml LIF (Millipore, ESG-1106).
Differentiation was adapted from the previously 
described hanging drop method, with some modifications 
[22, 23]. Briefly, cells were cultured in a medium made 
of DMEM (GIBCO 61965-026), with 15% ES-FCS (Mil-
lipore ES-009B), 1× Penicillin/Streptomycin (GIBCO 
15140), 1× MEM NEAA (GIBCO 11140-035) and 0.1 mM 
β-mercaptoethanol (SIGMA M-7522). Embryoid bod-
ies (EBs) were formed by hanging the cells in the form of 
drops on the lids of petri dishes at a concentration of 25 
cell/µl. After 2 days, these EBs were dropped into non-TC 
treated petri dishes and were grown in suspension culture for 
another 2 days. At day 4, the EBs were plated in 0.1% gelatin 
coated tissue culture dishes and the medium was changed 
every day till day 15.
RNA extraction and sequencing
RNA was extracted from two different biological samples 
of both WT and Hira-null cells at day 0 and day 15 using 
TRIzol reagent (Life technologies 15596-018) following 
the manufacturer’s instructions. The quality and quantity 
of RNA were determined using Nanodrop spectrophotom-
eter ND-1000 (Lab tech) and using High Sensitivity RNA 
screenTape®, samples with RIN of seven or more were 
used for subsequent library preparation. Library prepara-
tion was done using KAPA stranded mRNA-seq kit (KAPA-
BIOSYSTEMS KK8421) and KAPA mRNA capture kit 
(KAPABIOSYSTEMS KK8441). RNA sequencing was 
performed by Illumina NextSeq 500, with the production 
of paired-end reads. Reads were aligned to mouse genome 
mm9 using bowtie [24] and differential expression was pro-
cessed using Deseq package version 1.6.3. The produced 
gene lists were sorted using an adjusted p value ≤ 0.05 and 
an absolute fold change of ± 2. Gene Ontology analysis was 
done using DAVID bioinformatics functional annotation 
tool [25]. Enrichment analysis was performed using gene 
set enrichment analysis (GSEA) software and the candidate 
genes were selected using the GSEA lead Edge tool [26]. 
Functional enrichment was visualized using Cytoscape to 
produce enrichment maps [27].
Reverse transcription and quantitative real time 
PCR
The High-Capacity RNA-to-cDNA™ Kit (Thermo fisher 
4387406) was used to obtain cDNA and was used accord-
ing to the manufacturer’s instructions. Primers for qRT-
PCR were designed using the primer-blast tool of NCBI. 
The amplicon size was set between 70 and 200 bp (bp). 
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Quantitative real time PCR (qRT-PCR) was performed on 
the CFX96 Touch™ Real-Time PCR Detection System 
using SYBR green (BIO-RAD 1708882) on three biologi-
cal replicates and analysis was done using the standard 
curve method. Results were normalized to Gapdh.
Native ChIP followed by qPCR
Native ChIP was performed on 1 × 107 cells as previously 
described [10, 11]. Briefly, the cell pellets were lysed and 
chromatin was digested using MNase (Sigma N5386) 
at 37 °C with an ideal fragmentation between 200 and 
1000 bp. The reaction was stopped using 5 mM EDTA. 
HA antibody was collected with dynabeads (Invitrogen, 
112.03D, 112.01D) from 12AC5 hybridoma supernatants 
and then incubated with the lysates overnight at 4 °C. After 
several washes, the samples were treated with proteinase K 
and RNAse. DNA was purified using the PCR-purification 
Qiagen kit (28104). Quantitative real time PCR following 
ChIP (q-ChIP) or ChIP-seq were performed.
Primers for validation of ChIP-seq by q-ChIP were 
designed as follow; H3.3 significant peaks were uploaded 
in Integrative Genome browser (IGV). H3.3 enriched and 
depleted regions were identified. The corresponding nucle-
otide sequences were then extracted and used for primer 
design using NCBI primer design tool (https ://www.ncbi.
nlm.nih.gov/tools /prime r-blast /).
ChIPseq and data analysis
The eluted DNA from both Input and ChIP was processed 
through library preparation using the NEB DNA Ultra kit 
and selecting fragment sizes of around 200 bp. Samples 
were sequenced using Illumina NextSeq 500, with the pro-
duction of paired-end reads. Reads were aligned to mouse 
genome mm9 using BOWTIE 1.1.2 allowing no more than 
three mismatches [28]. Samtools 1.3.1 was used to gener-
ate BAM files, remove duplicates, sort and index [29]. 
MACS 1.4.2 was used for peak calling using the default 
parameters (p value ≤ 10−5) [30]. BEDTOOLS intersect 
with (–v) option was used to generate the HIRA-depend-
ent H3.3 peaks, after excluding the peaks in the Hira-null 
sample [31]. Gene lists were generated within + 10 kb of 
the TSS, in the gene body and 200 bp dowstream TES 
using the PAPST (Peak Assignment and Profile Search 
Tool) tool [32]. Genome-wide distribution of the H3.3 
ChIP-seq peaks was analyzed from both bed and wig files 
using the cis regulatory element annotation tools (CEAS) 
software [33]. The HIRA-dependent H3.3 peaks resulted 
from the subtraction of the Hira-null peaks from the WT 
peaks using bedtools.
Results
Cardiac markers are dysregulated in the absence 
of HIRA during early cardiomyocyte differentiation
WT and Hira-null mESCs were differentiated towards a 
cardiac mesodermal lineage using an adapted hanging 
drop protocol to increase the cardiomyocyte yield [22, 
23]. Beating foci were present from day 8 of differentia-
tion in both WT and Hira-null cells. These foci increased 
gradually in size during differentiation until reaching 
60–70% confluence at day 15. These beating areas arose 
concomitantly with the expression of the cardiac transcrip-
tion factor Nkx2.5 at day 8 [20]. We confirmed the expres-
sion of Gata4, Mef2c, Myh6 and Myh7, as cardiac specific 
marker at day 15 in both WT and Hira-null cells, and the 
expression of the pluripotency markers Nanog and Pou5f1 
at day 0, by qRT-PCR (Fig. 1a). We then sequenced the 
total RNA in undifferentiated and in differentiated WT 
and Hira-null cells at day 15. We compared the expressed 
genes observed in our experiment at day 15 with the data-
set previously published by Wamstad et al. at the cardio-
myocyte (CM) stage. We found that 68.6% and 67.4% of 
the expressed genes in WT and Hira-null dataset respec-
tively overlap with the reported CM stage datasets, indicat-
ing that loss of HIRA does not prevent general cardiogenic 
differentiation.
Gene ontology (GO) biological process analysis was 
performed on the genes expressed in WT and Hira-null 
differentiated cardiomyocytes. Genes related to heart 
development and morphogenesis were expressed in both 
cell types, indicating successful differentiation into car-
diac lineage in both cells (Fig. 1b). However, GO anal-
ysis of the differentially expressed genes (DEGs) show 
that genes related to cardiovascular development were 
relatively depleted in Hira-null compared to WT mESCs-
differentiated cardiomyocytes (p value = 4.1 × 10−21). On 
the contrary genes related to the nervous system develop-
ment were upregulated in the absence of HIRA. We found 
1680 DEGs of which 1641 encode known genes includ-
ing 108 cardiac genes and 39 were non-coding RNAs (p 
value ≤ 0.05 and FC = ± 2) (Fig. 1c).
Gene Set Enrichment Analysis (GSEA) was per-
formed on the DEGs and we identified 52 gene sets nega-
tively enriched and 54 gene sets positively enriched in 
the absence of HIRA (p value ≤ 0.01 and FDR ≤ 0.1). 
Enrichment map was used to visualize and function-
ally categorize these different gene sets, and showed an 
under representation of GO-terms related to cardiovas-
cular development, immune system development and 
DNA repair, and over representation of GO terms related 
to nervous system development and neurotransmission 
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(Fig. 2a). Accordingly, the gene sets related to cardiac 
septum development and cardiac chamber development 
were both negatively enriched (Fig. 2b). We then examined 
the genes that were common in the different cardiovascular 
development gene sets using the lead edge analysis tool in 
GSEA. We found that Gata4, Gata6, Hand1, Hand2, Isl1 
and Tbx2, and other genes represented in Fig. 2c, were 
common in several gene sets. We then validated a subset 
of these genes by qRT-PCR from independently isolated 
mRNA sample sets (Fig. 2d).
Altogether, the expression of cardiovascular develop-
ment-related genes, and more precisely cardiac chamber and 
septal development associated genes was down regulated in 
the absence of HIRA.
HIRA affects calcium signalling and vascular smooth 
muscle contraction pathways
We then investigated the pathways affected by the absence of 
HIRA. KEGG pathway analysis was done on the pre-ranked 
list of DEGs using GSEA (p value ≤ 0.05 and FC = ± 2). 
Interestingly, calcium signalling pathway was the most posi-
tively enriched (normalized enrichment score (NES) = 1.82, 
p value = 0.019 and FDR = 0.19). In addition, axon guid-
ance and neuroactive ligand-receptor interaction pathways, 
two pathways related to the nervous system, were positively 
enriched. Conversely, the vascular smooth muscle contrac-
tion pathway was negatively enriched (NES = − 1.63, p 
value = 0.026 and FDR = 0.17). Considering the studies that 
link HIRA to interferon-stimulated genes [34], it is inter-
esting to mention that leukocyte transendothelial migration 
pathways, which is related to the immune system is also 
negatively enriched (Fig. 2e).
HIRA‑dependent H3.3 deposition co‑localizes 
with active enhancer loci in WT cells and shifts 
to distal intergenic regions in the absence of HIRA
We previously showed that H3.3 deposition at the cardiac 
enhancer, Tte, is HIRA dependent [20]. However, there has 
been no study investigating the genome-wide effect of HIRA 
on the H3.3 deposition during the early stages of cardio-
vascular development. We therefore performed H3.3-HA 
ChIP-seq on undifferentiated mESCs and differentiated car-
diomyocytes at day 15 that contained about 60% of beating 
foci and 67% of transcriptome similarly to the previously 
published CM stage [7].
In WT-differentiated cardiomyocytes, H3.3 was deposited 
most abundantly in the intronic (53.3%) region with lesser 
deposition in the distal intergenic region (23.4%), and the 
promotor region (9.2%). In the absence of HIRA, the pro-
portion of H3.3 deposition increased at the distal intergenic 
region (42.2%) compared to the intronic region (29%) and 
the promotor region (3%) (Fig. 3a). We identified 14680 
HIRA-dependent H3.3 enrichment peaks encompassing 
+10 kb upstream of the TSS, the gene body or 200 bp down-
stream of the TES of 4703 annotated genes. GO analysis 
showed enrichment of DNA-dependent regulation of tran-
scription processes. We then compared these with the DEG 
list and found 319 in common.
Interestingly, 60 of the genes enriched for HIRA-depend-
ent H3.3 deposition were related to heart development by 
GO analysis. We then compared our datasets with previ-
ously published datasets for the known enhancer marks 
H3K4me1 and H3K27ac in cardiomyocyte-differentiated 
mESCs [7]. We identified that 31.6% (4642/14,680) of the 
total HIRA-dependent H3.3 enrichment peaks overlapped 
with both the active enhancer histone marks H3K4me1 and 
H3K27ac implicating that approximately one-third of the 
HIRA-dependent H3.3 deposition is at active enhancer sites 
(Fig. 3b).
In conclusion, the absence of HIRA leads to a decrease in 
the deposition of H3.3 in the intronic and promoter regions. 
We also show that about third of HIRA-dependent H3.3 
peaks co localize with active enhancers loci.
HIRA‑dependent H3.3 deposition directly influences 
the transcription of Meis1, Gata6 and Tbx2
We next investigated the co-localization of HIRA-dependent 
H3.3 deposition with some previously published ChIPseq 
datasets of cardiac transcription factors (NKX2.5, GATA4, 
TBX5 [35] and SRF [36]). We found that 1607 of the HIRA-
dependent H3.3 peaks (10.93%) overlapped with NKX2.5 
peaks, 1420 peaks (9.67%) overlapped with SRF peaks, 
937 peaks (6.38%) overlapped with GATA4 peaks and 450 
peaks (3.06%) overlapped with TBX5 peaks. Since we previ-
ously showed that HIRA and NKX2.5 bind to the common 
enhancer Tte [20], we focussed on identifying the colocali-
zation of HIRA dependent H3.3 deposition and NKX2.5 at 
the enhancer loci and/or at the promotor site of three cardiac 
transcription factors Meis1, Gata6 and Tbx2, which were 
downregulated in the absence of HIRA (Fig. 2d). These are 
known to be associated with cardiac septal defects, as we 
observed in our cardiac mesoderm Hira-conditional mice.
MEIS1 is a homeobox protein found to influence heart 
development. Mouse embryos lacking MEIS1 showed 
VSDs and overriding of aorta [37]. We found several HIRA-
dependent H3.3 enrichment sites in the gene body of Meis1 
(Fig. 4a). One of the most H3.3-enriched loci co-localizes 
with NKX2.5 at an enhancer locus marked by H3K4me1 and 
H3K27ac. We validated this enrichment by ChIP followed 
by qPCR using primers designed for this locus.
TBX2 is a member of the T-box transcription factor gene 
family. Absence of TBX2 leads to outflow tract septation 
defects [4]. We found HIRA dependent H3.3 enrichment in 
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the promoter region, 1.1 kb from the TSS. This enrichment 
peak overlaps with H3K4me3 enrichment [7] and NKX2.5 
(Fig. 4a). We validated this result by ChIP followed by qPCR 
using primers designed specifically for this locus (Fig. 4b).
GATA6 is a zinc finger transcription factor that plays a 
role in heart development. Lack of GATA6 has been asso-
ciated with septal and outflow tract defects [38]. HIRA-
dependent H3.3 enrichment was detected at approximately 
5.5 kb from the TSS (Fig. 4a). This enrichment, that we vali-
dated by ChIP followed by qPCR (Fig. 4b), co-localizes with 
NKX2.5 and H3K4me1 suggesting an active role of HIRA 
in the transcription of Gata6. Interestingly, this locus has 
been reported previously to be an enhancer for Gata6 [39].
Altogether, HIRA-dependent H3.3 is enriched at previ-
ously identified enhancer loci, essential for the expression of 
the cardiac transcription factors MEIS1, TBX2 and GATA6 
at the early cardiomyocyte stage.
Discussion
Heart development is a complex tightly regulated process 
requiring strict control of temporal gene expression [40–42] 
and involving epigenetic regulation [43]. We examined the 
role of the H3.3 histone chaperone HIRA in the early stages 
of heart development using an in vitro mESC differentiation 
model. We successfully differentiated both WT and Hira-
null mESCs into cardiomyocytes. This was evidenced by 
the enrichment of heart development and morphogenesis 
GO terms.
We report new direct targets of HIRA-mediated H3.3 dep-
osition, which are transcription factors known to be involved 
in cardiac septum formation. We previously demonstrated 
in vivo that mesodermal conditional Hira-null embryos pre-
sented with a fully penetrant phenotype of ventricular septal 
defect [20]. In that same study, we focussed on the dysregu-
lation of expression of Tnni2 and Tnnt3, suggesting a mecha-
nism in which HIRA with NKX2.5 binds to their common 
enhancer Tte to down regulate their expression. We herein 
predict further targets of the same mechanism: co-occupancy 
of HIRA and NKX2.5 at the enhancers of Meis1 and Gata6, 
and at the promoter of Tbx2 to activate their expression. 
Further studies will be needed to investigate the downstream 
effect of HIRA on these new targets in vivo, and to explore 
the interactions of HIRA and NKX2.5 at these loci.
Interestingly, knockout of Meis1 is associated with 
VSD and overriding aorta in mice [37], and an increased 
cardiomyocyte proliferation in zebrafish, suggesting a 
Fig. 3  Genome wide distribution of H3.3 in WT and Hira-null differ-
entiated cardiomyocytes and motif analysis of the significant peaks. 
a Pie chart showing the distribution of H3.3 over different genomic 
regions in WT and Hira-null differentiated cardiomyocytes as indi-
cated. b Venn diagram showing the overlap between HIRA-depend-
ent H3.3 peaks and the common peaks of H3K4me1 and H3K27ac. 
(Color figure online)
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role in the cell cycle [44]. In our differentiated cardio-
myocytes, Meis1 was down regulated (FC = − 2.5) in the 
absence of HIRA. Notably, there was co-localization of 
HIRA-dependent H3.3 deposition with NKX2.5 binding 
sites at a previously identified enhancer site. A previ-
ous study showed that the sequential binding of MEIS1 
then NKX2.5 to enhancers can influence cardiogenesis 
[45]. Taken together with our previously published find-
ing, which showed diminished binding of NKX2.5 at the 
enhancer site Tte in the absence of HIRA, we hypothesize 
that the absence of HIRA leads to a diminished expression 
of Meis1 and then to a diminished binding of NKX2.5 to 
the MEIS1-NKX2.5 target sites, thereby disrupting cardiac 
septum morphogenesis.
Similarly, Gata6 expression was down regulated 
(FC = − 6.1) in the absence of HIRA at day 15 of differen-
tiation, and we identified HIRA-dependent H3.3, H3K4me1 
and NKX2.5 enrichments co-localising at 5.5 kb upstream of 
the TSS of Gata6 in WT cells at day 15 of differentiation. It 
is interesting to note that the identical locus had been shown 
previously to be an enhancer bound by NKX2.5 and regu-
lating Gata6 expression in developing murine hearts [39].
TBX2 plays an essential role in the atrioventricular canal 
and OFT development [4]. We found HIRA-dependent H3.3 
deposition at the promotor of Tbx2 in WT cells differenti-
ated at day 15 and a down regulation of Tbx2 expression 
(FC = − 4.6) in the absence of HIRA at day 15 of differentia-
tion. This locus coincides with known NKX2.5 binding sites 
and a peak of the active transcription mark H3K4me3. This 
result suggests that HIRA may play a role in the atrioventric-
ular canal and the OFT development by influencing the tran-
scription of Tbx2 through H3.3 deposition at its promotor.
In addition, we found that calcium signalling pathway 
was significantly upregulated in the absence of HIRA at 
day 15 of differentiation. Calcium signalling controls sev-
eral physiological processes in the heart, including cardiac 
contractility [46]. KEGG calcium signalling pathway is 
normally required in ESC-derived cardiomyocytes [47]. We 
previously reported two cardiac genes involved in contract-
ibility to be up regulated in the hearts of cardiac mesoderm 
Hira-conditional mice. Further investigations on cardiac 
contractility in Hira-mutant mice would be interesting.
Outside of heart development, it is of interest to note that 
in our study, gene sets involved in DNA repair, the develop-
ment of the immune and nervous systems were significantly 
dysregulated in the absence of HIRA. Of relevance, HIRA 
has been shown to have an essential role in transcriptional 
recovery after DNA damage [48, 49], and several studies 
link HIRA-dependent H3.3 deposition with the induction 
of stress responsive associated genes following interferons 
and heat-shock stimulations [34, 50]. Absence of HIRA in 
neural progenitors resulted in decreased proliferation and 
increased neuronal differentiation [51]. Our study provides 
new subsets of genes that could be investigated further in 
these areas.
In conclusion, we show that cardiovascular development-
related genes are expressed in both WT and Hira-null differ-
entiated cardiomyocytes with a significant lower expression 
in Hira-null cells. We show that 31.6% of HIRA-dependent 
H3.3 peaks co-localize with active enhancers loci. We found 
that HIRA directly influence the expression of the cardiac 
transcription factors Meis1, Gata6 and Tbx2. We suggest that 
HIRA influences their expression through the deposition of 
H3.3 at their enhancers, supporting our previous published 
model that HIRA acts at enhancers during cardiovascular 
development, and potentially in concert with NKX2.5 [20].
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